<?xml version="1.0" encoding="UTF-8"?>
<p>Larvicidal activities of optimized nanoemulsions, F48 for 
 <italic>An</italic>. 
 <italic>stephensi mysorensis</italic> and F44 for 
 <italic>An</italic>. 
 <italic>stephensi intermediate</italic>, were precisely performed as mentioned before. The mortality caused by each formulation was compared with their corresponding PREO LC
 <sub>50</sub>, 11.5 ppm for 
 <italic>An</italic>. 
 <italic>stephensi mysorensis</italic> and 12.5 ppm for 
 <italic>An</italic>. 
 <italic>stephensi intermediate</italic>.
</p>
